Alkermes plc is a prominent biopharmaceutical company focusing on the development and commercialization of innovative medicines aimed at addressing unmet medical needs in major therapeutic areas such ... Alkermes plc is a prominent biopharmaceutical company focusing on the development and commercialization of innovative medicines aimed at addressing unmet medical needs in major therapeutic areas such as neuroscience and oncology. As a leader in its field, Alkermes plc combines its scientific expertise with a commitment to improving patient outcomes, developing a pipeline of products that include treatments for serious conditions like schizophrenia, bipolar disorder, and alcohol and opioid dependence. The company distinguishes itself through its integrated approach to drug development, which includes a comprehensive system for clinical trial design, regulatory strategy, and formulation science. Alkermes plc plays a significant role in the healthcare market by bringing transformative therapies to patients worldwide, collaborating with academic institutions, pharmaceutical companies, and health organizations to expand the impact of its innovations. Headquartered in Dublin, Ireland, with research and manufacturing facilities in Massachusetts and Ohio, Alkermes plc leverages its multinational presence to advance its mission of making a positive difference in the lives of patients, while maintaining robust financial performance in the competitive biopharmaceutical landscape.Show lessShow more

Disclosures ESG Data Financial Data

GHG Emissions Climate Targets EU Taxonomy Energy Waste Management

Data not available

No Climate Targets data disclosed by Alkermes

We reviewed Alkermes's website and available disclosure materials for the 2023 reporting period and did not identify any reported Climate Targets data.

If you would like us to review newly published materials or reassess the most recent disclosures, you can submit a data update request.

Would you like us to review Alkermes's data?

Start your 30-day free trial to request a data review for Alkermes.

Start Free Trial

Legal Center Contact Us